ARCH CHEMICALS, INC. (NYSE: ARJ) announced sales for the
third quarter of 2009 of $350.5 million, compared to $367.9 million
for the third quarter of 2008. Higher pricing and the benefit from
the Advantis acquisition were more than offset by lower volumes and
unfavorable foreign exchange.
Third quarter earnings per share for 2009 were $0.41 per share
on $10.3 million of income, which included a charge of $0.7
million, net of tax, or $0.03 per share, related to estimated
executive severance. Excluding the estimated executive
severance, 2009 earnings from continuing operations were $0.44 per
share. Third quarter earnings per share from continuing operations
for 2008 were $0.68 on $17.0 million of income. The 2008 results
included a net benefit of $0.31 per share from the favorable
antidumping ruling for the second period of review and a charge
equal to $0.03 per share, related to a pension settlement.
Excluding the pension settlement, 2008 earnings from continuing
operations were $0.71 per share.
Segment operating income was $20.4 million in 2009 compared to
$29.3 million in 2008.
“I am pleased by our strong third quarter results,” said Arch
Chemicals’ Chairman, President and CEO Michael E. Campbell. “We
realized increased selling prices in several of our businesses and
saw higher demand for our health and hygiene biocides. We also
benefited from significant cost reduction efforts across all
businesses, which mitigated continuing unfavorable sales
comparisons across most of our businesses and the protracted impact
of unfavorable weather patterns in our North American HTH water
products business.”
The following compares segment sales and operating income (loss)
for the third quarters of 2009 and 2008 (including equity in
earnings of affiliated companies and excluding restructuring and
impairment):
Treatment Products
Treatment Products reported sales of $309.7 million and
operating income of $25.2 million in 2009 compared with sales of
$310.9 million and operating income of $31.2 million in 2008.
HTH Water Products
HTH water products reported sales of $128.1 million and
operating income of $9.0 million for 2009 compared to sales of
$111.9 million and operating income of $17.3 million for 2008.
Sales increased $16.2 million, or 14 percent. Excluding the
impact of the acquisition of the water treatment chemicals business
of Advantis Technologies ($17.0 million), sales decreased $0.8
million, or one percent. Improved pricing across all regions was
offset by lower volumes in North America and unfavorable foreign
exchange. Lower volumes in the North American residential business,
principally due to unfavorable weather, were partially offset by
higher volumes in Europe and South Africa.
Operating income decreased $8.3 million as 2008 included the
benefit related to the favorable antidumping duty ruling for the
June 1, 2006 to May 31, 2007 review period of $11.5 million.
Excluding the impact of the ruling, operating income improved $3.2
million as higher pricing and the positive contribution of the
acquisition of Advantis more than offset lower volumes and higher
product costs.
Personal Care and Industrial Biocides
Personal care and industrial biocides reported sales of $77.8
million and operating income of $13.6 million compared to sales and
operating income of $78.8 million and $12.3 million, respectively,
in 2008.
Sales decreased $1.0 million, or one percent, as lower
volumes more than offset improved pricing. Reduced demand for
industrial biocides used in antifouling paints and metalworking
fluids, due to the global economic recession, was partially offset
by increased demand for biocides used in antidandruff products and
other health and hygiene applications, partly due to timing. The
improved pricing principally related to health and hygiene
products.
Operating income increased $1.3 million as higher pricing and
favorable foreign exchange were partially offset by lower volumes
and higher plant costs related to the new manufacturing facilities
in China.
Wood Protection and Industrial Coatings
Wood protection and industrial coatings reported sales of $103.8
million and operating income of $2.6 million compared to sales and
operating income of $120.2 million and $1.6 million, respectively,
in 2008.
Sales decreased $16.4 million, or 14 percent, as improved
pricing in the wood protection business was more than offset
by lower volumes and unfavorable foreign exchange in both
businesses. In the wood protection business, lower residential and
industrial sector volumes in the North American and Asia-Pacific
regions due to the continued depressed conditions in global
construction markets were partially offset by higher global prices.
In the industrial coatings business, the lower volumes were
attributable to poor economic conditions throughout Europe.
Operating income was $1.0 million higher than the prior year,
due to the wood protection business, as improved pricing and
reduced costs more than offset lower volumes and unfavorable
foreign exchange. In the industrial coatings business, lower
volumes were offset by favorable raw material costs and
cost-reduction initiatives.
Performance Products
Performance Products reported sales of $40.8 million and
operating income of $3.4 million compared with sales and operating
income of $57.0 million and $5.7 million, respectively, in
2008.
Performance urethanes sales decreased $16.7 million. Pricing was
below the third quarter 2008 as a result of lower raw material
costs. Volumes were lower than prior year due to the downturn in
the U.S. economy. Operating income decreased by $3.3 million as a
result of the lower volumes.
Hydrazine sales and operating income were slightly higher than
2008.
General Corporate Expenses
General corporate expenses increased due to estimated executive
severance costs which were partially offset by lower U.K. pension
expense.
Other Items
During September 2009, the Company issued $75 million principal
amount of unsecured Series A Senior Notes (the Notes) to certain
affiliates of Prudential Investment Management, Inc. (Prudential).
The Notes mature in August 2016 and bear a fixed annual interest
rate of 6.70%. Proceeds from the issuance of the Notes were used
primarily to pay down a portion of the Company’s revolving credit
facility. The Notes were issued under a $150 million Note Purchase
and Private Shelf Agreement that also provides for the additional
purchase by Prudential of notes, in amounts to be mutually agreed,
up to a maximum of $75 million over the next three years on terms
to be determined.
In October 2009, the Company entered into a new trade accounts
receivable securitization facility with PNC Bank and its affiliate,
Market Street Funding LLC, which will provide up to $80 million of
funding to the Company. This facility replaces the Company’s
previous securitization facility with SunTrust Bank and its
affiliates.
2009 Outlook
The Company has narrowed the range of its earnings forecast for
the full-year 2009 from continuing operations and before estimated
executive severance to be in the $1.65 to $1.80 per share range
compared to the Company’s previous guidance of $1.60 to $1.80.
Full-year sales are expected to be approximately six to seven
percent lower than 2008, as the contribution from the acquisition
of Advantis and higher pricing should be more than offset by lower
volumes and unfavorable foreign exchange. The Company now expects
depreciation and amortization to be in the $45 to $50 million
range. Capital spending continues to be in the $30 to $35 million
range and the effective tax rate remains in the 34 to 35 percent
range.
The Company anticipates results from continuing operations to be
in the range of breakeven to a loss of $(0.15) per share for the
fourth quarter of 2009. Fourth quarter 2008 loss from continuing
operations was $(0.75) per share, which included a net charge of
$0.97 per share primarily for a goodwill impairment charge.
Excluding the net charge, earnings per share from continuing
operations for the fourth quarter of 2008 were $0.22. The expected
decrease in the fourth quarter results is principally due to lower
results for the industrial biocides and performance urethanes
businesses. The decrease for industrial biocides is principally the
result of higher plant costs related to the Company’s new
manufacturing facilities in China and unfavorable foreign exchange.
The Company expects lower demand and higher raw material costs will
negatively impact the performance urethanes business.
Commenting on the Company’s full-year outlook, Mr. Campbell
said: “We remain on target to achieve our earnings forecast. While
end-use demand for our products appears to have stabilized, we are
not yet experiencing a marked recovery in demand. Our results are
benefiting from numerous supply chain, manufacturing and SG&A
cost-reduction initiatives across all of our businesses.” He added:
“Our relentless commitment to improve operating margins by raising
prices wherever possible, aggressively reducing costs, optimizing
our portfolio and maximizing cash generation will sustain Arch
through these challenging times, and is the driver of our long-term
profitable growth.”
Note: All references to earnings per share above reflect diluted
earnings per share.
About Arch
Headquartered in Norwalk, Connecticut (USA), Arch Chemicals,
Inc. is a global Biocides company with annual sales of
approximately $1.5 billion. Arch and its subsidiaries provide
innovative, chemistry-based and related solutions to selectively
destroy and control the growth of harmful microbes. The Company’s
concentration is in water treatment, hair and skin care products,
treated wood, preservation and protection applications such as for
paints and building products, and health and hygiene applications.
Arch Chemicals operates in two segments: Treatment Products and
Performance Products. Together with its subsidiaries, Arch has
approximately 3,000 employees and manufacturing and
customer-support facilities in North and South America, Europe,
Asia, Australia and Africa. For more information, visit the
Company’s Web site at http://www.archchemicals.com.
- Listen in live to Arch
Chemicals’ third quarter 2009 earnings conference call on
Wednesday, November 4, 2009 at 11:00 a.m. (ET) at
http://www.archchemicals.com.
- If members of the public wish to
access Arch’s live earnings call in a listen-only mode, dial: (877)
397-0297, passcode 8564523, in the United States, or (719)
325-4861, passcode 8564523, outside the United States.
- A telephone replay will be
available from 1:00 p.m. on Wednesday, November 4, 2009 until 6:00
p.m. (ET) on Wednesday, November 11, 2009. The replay number is
(888) 203-1112, passcode 8564523; from outside the United States,
please call (719) 457-0820, passcode 8564523.
Except for historical information contained herein, the
information set forth in this communication contains
forward-looking statements that are based on management's beliefs,
certain assumptions made by management and management's current
expectations, outlook, estimates and projections about the markets
and economy in which the Company and its various businesses
operate. Words such as "anticipates," "believes," "estimates,"
"expects," "forecasts," "intends," "opines," "plans," "predicts,"
"projects," "should," "targets" and variations of such words and
similar expressions are intended to identify such forward-looking
statements. These statements are not guarantees of future
performance and involve certain risks, uncertainties and
assumptions ("Future Factors"), which are difficult to predict.
Therefore, actual outcomes and results may differ materially from
what is expected or forecasted in such forward-looking statements.
The Company undertakes no obligation to update publicly any
forward-looking statements, whether as a result of future events,
new information or otherwise. Future Factors which could cause
actual results to differ materially from those discussed include
but are not limited to: general economic and business and market
conditions; continued weakening in U.S., European and Asian
economies; increases in interest rates; changes in foreign
currencies against the U.S. dollar; customer acceptance of new
products; efficacy of new technology; changes in U.S. or foreign
laws and regulations; increased competitive and/or customer
pressure; loss of key customers; the Company's ability to maintain
chemical price increases; higher-than-expected raw material and
energy costs and availability for certain chemical product lines; a
change in the antidumping duties on certain products; increased
foreign competition in the calcium hypochlorite markets; inability
to obtain transportation for our chemicals; unfavorable court
decisions, including unfavorable decisions in appeals of
antidumping rulings, arbitration or jury decisions or tax matters;
the supply/demand balance for the Company's products, including the
impact of excess industry capacity; failure to achieve targeted
cost-reduction programs; capital expenditures in excess of those
scheduled; environmental costs in excess of those projected; the
occurrence of unexpected manufacturing interruptions/outages at
customer or Company plants; a decision by the Company not to start
up the hydrates manufacturing facility; unfavorable weather
conditions for swimming pool use; inability to expand sales in the
professional pool dealer market; the impact of global weather
changes; changes in the Company’s stock price; ability to obtain
financing at attractive rates; financial market disruptions that
impact our customers or suppliers; and gains or losses on
derivative instruments.
Arch Chemicals, Inc.
Condensed Consolidated
Statements of Income (a)
(In millions, except per share
amounts)
Three Months Nine Months
Ended September 30, Ended September 30,
2009 2008 2009
2008 Sales $ 350.5
$ 367.9 $ 1,058.4 $
1,184.6 Cost of Goods Sold (b) 250.1
258.7 737.7 845.0 Selling and
Administration 73.6 74.9 223.7
225.6 Research and Development 5.5 5.1
16.7 17.0 Restructuring and Other Expenses (c)
1.1 1.3 1.1 1.3 Interest Expense,
Net (d) 2.8 1.2
9.1 7.2
Income from Continuing
Operations Before Equity
in Earnings of Affiliated
Companies and Taxes
17.4 26.7 70.1 88.5 Equity in
Earnings of Affiliated Companies 0.2 0.1
0.4 0.2 Income Tax Expense
7.3 9.8 26.1
32.8 Net Income $
10.3 $ 17.0 $ 44.4
$ 55.9 Basic Income Per Common
Share $ 0.41 $ 0.68 $
1.78 $ 2.25 Diluted Income Per
Common Share $ 0.41 $ 0.68 $
1.77 $ 2.24 Weighted Average Common
Stock Outstanding - Basic 25.0 24.8 24.9
24.8 Weighted Average Common Stock Outstanding -
Diluted 25.1 25.0
25.0 25.0
(a)
Unaudited.
(b)
The three months and nine
months ended September 30, 2008 include an $11.5 million benefit
related to the favorable antidumping duty ruling for the period of
review from June 1, 2006 through May 31, 2007.
(c)
The three months and nine
months ended September 30, 2009 represent estimated executive
severance. The three months and nine months ended September 30,
2008 represent a charge related to a pension settlement associated
with severance recorded in 2007.
(d)
The three months and nine
months ended September 30, 2008 include $1.2 million of interest
income related to the favorable antidumping duty ruling.
Arch Chemicals, Inc.
Condensed Consolidated Balance
Sheets
(In millions, except per share
amounts)
September 30, December 31,
2009 (a) 2008 Assets:
Cash & Cash Equivalents $ 52.1 $
50.8 Restricted Cash 2.2 - Accounts
Receivable, Net (b)
162.5
184.2 Short-Term Investment (b) 24.1
56.0 Inventories, Net 214.1 216.1
Other Current Assets 20.3
19.6 Total Current Assets 475.3
526.7 Investments and Advances - Affiliated Companies at
Equity 1.7 1.5 Property, Plant and Equipment,
Net 214.0 212.2 Goodwill 205.2
199.6 Other Intangibles 183.3 183.0
Other Assets 99.6
109.4 Total Assets $
1,179.1 $ 1,232.4
Liabilities and Shareholders' Equity: Short-Term
Borrowings $ 20.3 $ 18.5 Current
Portion of Long-Term Debt 21.1 - Accounts
Payable 148.5 180.1 Accrued Liabilities
95.9 75.9
Total Current Liabilities 285.8 274.5
Long-Term Debt 216.5 314.5 Other
Liabilities 247.6
281.5 Total Liabilities 749.9
870.5 Commitments and Contingencies Shareholders'
Equity: Common Stock, Par Value $1 Per Share, Authorized
100.0 Shares: 25.0 Shares Issued and Outstanding (24.8 in
2008) 25.0 24.8 Additional Paid-in Capital
460.3 457.2 Retained Earnings 93.5
64.1 Accumulated Other Comprehensive Loss
(149.6 ) (184.2 )
Total Shareholders' Equity 429.2
361.9 Total Liabilities and
Shareholders' Equity $ 1,179.1
$ 1,232.4
(a)
Unaudited.
(b)
The Company sold certain
accounts receivable through an accounts receivable securitization
program (see Form 10-K for additional information). As a result,
accounts receivable have been reduced, and the Company's retained
interest in such receivables has been reflected as a short-term
investment. As of September 30, 2009, the Company had sold $40.0
million of participation interests in $64.1 million of accounts
receivable and, as of December 31, 2008, the Company had not sold
any participation interests in such accounts receivable.
Arch Chemicals, Inc.
Condensed Consolidated
Statements of Cash Flows (a)
(In millions)
Nine Months Ended September 30,
2009 2008 Operating Activities: Net
Income $ 44.4 $ 55.9 Adjustments
to Reconcile Net Income to Net Cash and Cash Equivalents
Provided by Operating Activities: Equity in Earnings of
Affiliates (0.4 ) (0.2 )
Depreciation and Amortization 35.0 33.7
Deferred Taxes 13.0 12.9 Restructuring
Payments (0.1 ) (0.7 ) Changes
in Assets and Liabilities, Net of Purchase and Sale of
Businesses: Accounts Receivable Securitization Program
40.0 - Receivables 28.6 (12.5
) Inventories 14.9 2.3 Other Current
Assets 0.3 0.7 Accounts Payable and Accrued
Liabilities (26.1 ) (34.9 )
Noncurrent Liabilities (b) (32.0 ) (8.2
) Other Operating Activities 1.7
(10.6 ) Net Operating
Activities 119.3
38.4 Investing Activities: Capital
Expenditures (20.1 ) (41.3 )
Businesses Acquired in Purchase Transaction 0.3
(0.2 ) Proceeds from Sale of a Business
0.5 3.7 Proceeds from Sale of Land and
Property - 0.7
Net Investing Activities (19.3
) (37.1 ) Financing
Activities: Long-Term Debt Borrowings 197.5
60.0 Long-Term Debt Repayments (277.4 )
(58.6 ) Short-Term (Repayments) Borrowings,
Net (1.7 ) (5.1 ) Dividends
Paid (15.0 ) (15.0 ) Other
Financing Activities (2.4 )
1.1 Net Financing Activities
(99.0 ) (17.6 )
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.3 0.1
Net Increase (Decrease) in Cash and Cash Equivalents
1.3 (16.2 ) Cash and Cash Equivalents,
Beginning of Year 50.8
73.7 Cash and Cash Equivalents, End of
Period $ 52.1 $
57.5
(a)
Unaudited.
(b)
Includes $40.2 million of U.S.
pension payments for the nine months ended September 30,
2009.
Arch Chemicals, Inc.
Segment Information (a)
(In millions)
Three Months Nine Months
Ended September 30, Ended September 30,
2009 2008 2009 2008
Sales: Treatment Products: - HTH
Water Products $ 128.1 $ 111.9
$ 433.3 $ 401.3 - Personal Care and
Industrial Biocides 77.8 78.8 219.4
246.8 - Wood Protection and Industrial Coatings
103.8 120.2
281.9 367.8
Total Treatment Products 309.7 310.9
934.6 1,015.9 Performance Products: -
Performance Urethanes 35.8 52.5 111.1
154.3 - Hydrazine 5.0
4.5 12.7
14.4 Total Performance Products
40.8 57.0
123.8 168.7 Total
Sales $ 350.5 $
367.9 $ 1,058.4 $
1,184.6 Operating Income (Loss) (b):
Treatment Products: - HTH Water Products (c) $
9.0 $ 17.3 $ 64.6 $
66.7 - Personal Care and Industrial Biocides
13.6 12.3 32.7 44.2 - Wood
Protection and Industrial Coatings 2.6
1.6 (3.4 )
5.3 Total Treatment Products
25.2 31.2 93.9 116.2 Performance
Products: - Performance Urethanes 2.4 5.7
5.3 3.4 - Hydrazine 1.0
- 2.2
0.2 Total Performance Products
3.4 5.7
7.5 3.6
28.6 36.9 101.4 119.8 General
Corporate Expenses (d) (8.2 )
(7.6 ) (21.8 )
(22.6 ) Total Segment Operating
Income including Equity in Earnings of Affiliated
Companies 20.4 29.3 79.6 97.2
Equity in Earnings of Affiliated Companies (0.2
) (0.1 ) (0.4 ) (0.2
) Restructuring (e) -
(1.3 ) -
(1.3 ) Total Operating Income
20.2 27.9 79.2 95.7 Interest
Expense, net (f) (2.8 )
(1.2 ) (9.1 )
(7.2 ) Income from Continuing Operations
before Equity in Earnings of Affiliated Companies and
Taxes $ 17.4 $
26.7 $ 70.1 $
88.5
(a)
Unaudited.
(b)
Includes equity in earnings of
affiliated companies.
(c)
The three months and nine
months ended September 30, 2008 include an $11.5 million benefit
related to the favorable antidumping duty ruling for the period of
review from June 1, 2006 through May 31, 2007.
(d)
Includes certain general
expenses of the corporate headquarters that are not allocated to
the business segments, including costs associated with the
Company's accounts receivable securitization program and certain
pension expenses. In addition, the three months and nine months
ended September 30, 2009 include estimated executive
severance.
(e)
The three months and nine
months ended September 30, 2008 represent a charge related to a
pension settlement associated with severance recorded in
2007.
(f)
The three months and nine
months ended September 30, 2008 include $1.2 million of interest
income related to the 2008 favorable antidumping duty
ruling.
Arch Chemicals, Inc.
Reconciliation of GAAP to
Non-GAAP Information
(In millions, except per share
amounts)
The following table reconciles income and diluted income per
share from continuing operations for the three months ended
September 30, 2009 to income and diluted income per share from
continuing operations before executive severance. The table is
being provided in order to provide comparability to the Company's
earnings guidance for the three months ended September 30,
2009.
Three Months Ended September
30, 2009 Income
EPS Income from Continuing Operations
$ 10.3 $ 0.41 Add: Executive
severance, net of tax 0.7
0.03 Income from Continuing Operations before executive
severance $ 11.0 $
0.44
The following table reconciles income and diluted income per
share from continuing operations for the three months ended
September 30, 2008 to income and diluted income per share from
continuing operations before a pension settlement associated
with severance which was recorded in 2007. The table is being
provided in order to provide comparability to the three
months ended September 30, 2009.
Three Months
Ended September 30, 2008 Income
EPS Income from Continuing
Operations $ 17.0 $ 0.68 Add:
Pension settlement, net of tax 0.8
0.03 Income from Continuing Operations
before the pension settlement $ 17.8
$ 0.71
The following table reconciles the estimate of diluted income
per share from continuing operations for full year 2009 to the
estimate of diluted income per share from continuing
operations for full year 2009 before executive severance.
The table is being provided in order to reconcile the Company's
earnings guidance for full year 2009 to GAAP.
Year Ended December 31, 2009
Diluted Income Per Share: Income from
Continuing Operations $ 1.62 - $ 1.77 Add: Executive
severance, net of tax 0.03 Income from
Continuing Operations before executive severance $
1.65 - $ 1.80
The following table reconciles diluted loss per share from
continuing operations for the three months ended December 31, 2008
to diluted income per share from continuing operations before
impairment and other (gains) and losses. The table is being
provided in order to provide comparability to the Company's
earnings guidance to the three months ended December 31,
2009.
Three Months
Ended December 31, 2008 Diluted Income (Loss) Per
Share: Loss from Continuing Operations $
(0 .75) Add: Impairment charge, net of tax (a)
1 .02 Less: Other (Gains) and Losses, net of tax
(b) (0 .05) Income from Continuing
Operations before Impairment and Other (Gains) and Losses
$ 0 .22 (a)
Represents a $24.6 million
goodwill impairment charge for the industrial coatings business and
a $1.2 million pre-tax impairment charge of certain manufacturing
assets for the wood protection and industrial coatings
businesses.
(b)
Represents a $1.4 million
pre-tax gain from the reversal of penalties and interest related to
a Brazilian state import tax claim recorded in 2004 due to the
expiration of the statute of limitations and a $0.4 million pre-tax
gain from a revised estimate of shutdown costs related to the
completion of a contract with the U.S. Government in 2007.
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Lug 2023 a Lug 2024